Deep Track Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Deep Track Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-326,600	Closed	-$22.2M	–	80
2022 Q3	$22.2M	Sell	326,600 -3,320,090	-91%	-$183M	1.02%	36
2022 Q2	$117M	Buy	3,646,690 +1,342,007	+58%	+$39.3M	7.66%	1
2022 Q1	$79.8M	Buy	2,304,683 +304,683	+15%	+$9.11M	5.12%	5
2021 Q4	$58.5M	Buy	+2,000,000	New	+$62M	4.13%	6

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deep Track Capital's GBT Position: Q4 2022 in Review

Deep Track Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 326,600 shares — an estimated $22.2M sold.

Deep Track Capital first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $117M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Deep Track Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Deep Track Capital sold 326,600 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $22.2M.
Deep Track Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
Deep Track Capital's Global Blood Therapeutics, Inc. position peaked at $117M in Q2 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Deep Track Capital's 13F filing for Q4 2022, filed 14 Feb 2023.